A Comparison of the Effects of ORP-101 Versus Placebo in Adult Patients With Irritable Bowel Syndrome With Diarrhea (IBS-D)
Condition:   Irritable Bowel Syndrome With Diarrhea Interventions:   Drug: ORP-101;   Drug: Placebo Sponsors:   OrphoMed, Inc.;   PPD Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2019 Category: Research Source Type: clinical trials

Allogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Condition:   Diarrhea-predominant Irritable Bowel Syndrome Interventions:   Procedure: Allogeneic microbiota reconstitution;   Procedure: Placebo-Allogeneic microbiota reconstitution Sponsors:   University of Ulm;   Klinikum Ludwigsburg;   Helios Klinikum Krefeld;   Charite University, Berlin, Germany;   Assign International, Berlin, Germany Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 19, 2019 Category: Research Source Type: clinical trials

Randomised Controlled Study: Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS)
Condition:   Irritable Bowel Syndrome Intervention:   Other: dietary therapy Sponsor:   Sheffield Teaching Hospitals NHS Foundation Trust Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2019 Category: Research Source Type: clinical trials

A Study Comparing the Effectiveness and Convenience of Dietary Therapy for Irritable Bowel Syndrome (IBS)
Condition:   Irritable Bowel Syndrome Intervention:   Other: dietary therapy Sponsor:   Sheffield Teaching Hospitals NHS Foundation Trust Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 28, 2019 Category: Research Source Type: clinical trials

Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial
DiscussionThe TRITON trial aims to assess the effect of ondansetron across multiple centres. By defining ondansetron ’s mechanisms of action we hope to better identify patients with IBS-D who are likely to respond.Trial registrationISRCTN,ISRCTN17508514, Registered on 2 October 2017. (Source: Trials)
Source: Trials - August 19, 2019 Category: Research Source Type: clinical trials

Lactobacillus LB as Treatment for Irritable Bowel Syndrome With Predominance of Diarrhea (IBS-D)
Condition:   Irritable Bowel Syndrome With Diarrhea Interventions:   Drug: lactobacillus LB;   Other: placebo Sponsor:   Hospital General de Mexico Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 13, 2019 Category: Research Source Type: clinical trials